← Human Trials & Peer-Reviewed Studies
Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial.
Plain-language guide to PMID 23527013 (2013): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 23527013
- Journal
- PloS one
- Year
- 2013
- Study type
- Randomized Controlled Trial
- Authors
- Hossein-nezhad A et al. (3 authors)
- DOI
- 10.1371/journal.pone.0058725
- Registered trial
- NCT01696409
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults.
Why It Was Studied
Although there have been numerous observations of vitamin D deficiency and its links to chronic diseases, no studies have reported on how vitamin D status and vitamin D3 supplementation affects broad gene expression in humans.
Who Took Part
PubMed indexes the participants as young adults and adults, both men and women.
How the Study Was Run
The researchers set it up as a randomized and double-blind study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the participants and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
What Was Measured
The subject headings attached to it are Cholecalciferol, Gene Expression, Leukocytes, Oligonucleotide Array Sequence Analysis, Vitamin D, Vitamin D Deficiency and Vitamin D Response Element.
What This Means in Plain Language
The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc.
Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2013 (PloS one), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.